Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2024

Dec 31, 2024

34975_dirs_2024-12-31_64155ab4-9cc8-4751-911c-4baeb32baa2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2024-12-29

Reporting Person: Green James W (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-29 Common Stock F 56915 $1.98 Disposed 3054176 Direct
2024-12-29 Common Stock F 25310 $1.98 Disposed 3028866 Direct

Footnotes

F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested on December 29, 2024.

F2: Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 699,772 RSUs with performance based vesting conditions and (d) 1,996,584 shares of common stock beneficially owned by the Reporting Person.